Benign lipomatous neoplasm of of intra-abdominal organs

CD2_BENIGN_LIPO_INTRATHO

renal pelvis carcinoma: A carcinoma arising in the renal pelvis. The majority of renal pelvis carcinomas are transitional cell and less frequently squamous cell carcinomas.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D17.5& Cause of death: ICD-10 — D17.5& 2 out of 7 registries used, show all original rules.	123
4. Check minimum number of events None	123
5. Include endpoints None	123
6. Filter based on genotype QC (FinnGen only)	115

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D17
Name in latin: Neoplasma benignum lipomatosum organorum intra-abdominalium

NAME	CD2_BENIGN_LIPO_INTRATHO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D175
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D175
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign lipomatous neoplasm of of intra-abdominal organs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	625	394	228
Only index persons	590	378	212
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	60.98	60.98	60.94
Only index persons	60.09	60.23	59.85

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	115	67	48
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	63.77	61.00	67.62

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
119: Matched controls
1190

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D17.5

ICD-10 Finland

Benign lipomatous neoplasm of intra-abdominal organs

+∞

169.7

119

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

8.0

17.0

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

3.6

9.5

150

UJF32

NOMESCO Finland

Coloscopy

2.8

6.5

212

Z2221

NOMESCO Finland

Medical doctor

2.8

6.3

215

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

7.1

6.1

A02BC05

ATC

esomeprazole; systemic

2.6

6.1

361

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

5.5

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030467) Casts [#/volume] in Urine by Automated count

312

2.68

6.46

3.8

3.3

0.96

0.49

e6/l

0.35

225

(3018095) Leukocytes [#/volume] in Urine

405

2.67

6.43

4.9

4.1

45.63

136.52

e6/l

1.02

279

(3014051) Protein [Presence] in Urine by Test strip

290

2.67

6.35

3.2

3.4

—

0.33

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

194

2.70

5.79

3.4

3.1

0.69

1.04

e6/l

0.77

106

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

173

2.76

5.78

3.5

3.2

3.07

2.53

e6/l

0.12

(3002582) Erythrocytes [#/volume] in Urine

357

2.29

4.71

4.0

3.4

16.98

243.05

e6/l

0.64

264

(3035350) Ketones [Presence] in Urine by Test strip

571

2.22

4.03

3.8

4.1

0.00

13.42

estimate

—

121

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

196

2.29

3.93

1.2

1.3

5.79

7.57

u/ml

0.12

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

479

2.12

3.87

2.6

2.2

102.19

97.11

pmol/l

0.31

238

(3021601) Nitrite [Presence] in Urine by Test strip

568

2.16

3.81

3.8

4.0

0.00

estimate

—

120

(3009261) Glucose [Presence] in Urine by Test strip

576

2.11

3.57

3.8

4.1

0.22

0.00

estimate

—

112

(3015736) pH of Urine

457

1.93

3.09

3.8

3.7

6.27

6.22

0.13

249

(3000494) Fungus identified in Specimen by Culture

131

2.26

3.05

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

270

1.93

2.81

2.5

2.3

2.87

2.94

mg/l

0.07

238

(3026782) Osmolality of Urine

207

1.98

2.71

3.5

3.4

533.14

527.65

mosm/kgh2o

0.05

176

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.56

2.69

1.4

1.8

—

(3012516) Albumin [Mass/volume] in Urine

380

1.83

2.64

3.5

3.4

26.46

49.85

mg/l

0.73

249

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

210

1.94

2.59

1.3

8.61

34.56

iu/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

5.68

2.57

1.2

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

7.39

2.57

1.6

1.9

53.60

69.71

nmol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

113

1017

3.20

2.53

20.5

17.3

29.74

22.02

mg/l

1.28

838

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

493

1.76

2.36

3.0

—

estimate

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.39

2.36

1.0

1.2

—

(3002256) Pathology report gross observation

145

2.01

2.35

1.2

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

123

2.08

2.32

2.2

1.7

—

(3022145) Colonoscopy Study observation

131

2.04

2.29

1.7

1.3

—

(3006315) Basophils [#/volume] in Blood

555

1.75

2.28

5.3

6.0

0.04

e9/l

0.38

474

(1616796) Gas panel - Central venous blood

3.85

2.18

2.7

1.5

—

(3003694) ABO and Rh group [Type] in Blood

272

1.77

2.18

1.2

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

560

1.72

2.16

5.3

6.1

2.54

1.95

e9/l

0.26

496

(3000991) Gas panel - Venous blood

2.18

2.14

5.8

11.1

—

(3001604) Monocytes [#/volume] in Blood

552

1.71

2.12

5.3

6.0

0.59

0.57

e9/l

0.30

475

(3023368) Bacteria identified in Blood by Culture

319

1.72

2.08

4.3

4.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

395

1.67

1.99

4.1

4.2

4.94

9.37

mg/mmol

0.69

241

(40768804) Tissue Pathology biopsy report

442

1.66

1.98

2.6

2.1

—

(3013115) Eosinophils [#/volume] in Blood

569

1.67

1.96

5.5

6.3

0.18

0.19

e9/l

0.15

497

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

580

1.67

1.94

3.0

—

(3002032) Base excess in Venous blood by calculation

109

2.00

1.91

3.5

4.3

1.85

1.91

mmol/l

0.02

(3017143) Hepatitis C virus Ab [Presence] in Serum

102

2.03

1.89

1.5

1.6

—

(3019977) pH of Arterial blood

125

1.93

1.88

4.8

9.0

7.42

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

616

1.65

1.82

8.3

11.3

4.14

4.12

e9/l

0.03

541

(3042936) Bacteria identified in Isolate by Culture

159

1.81

1.78

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

176

1.77

1.75

3.1

2.6

21.63

23.32

0.32

163

(3018418) pH of Serum or Plasma

350

1.62

1.74

5.4

4.4

7.40

0.14

247

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

235

1.69

1.74

1.9

0.61

1.50

mg/l

2.09

194

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2.01

1.71

3.1

3.2

53.86

61.13

ml/min/173m2

—

(3012544) pH of Venous blood

114

1.91

1.69

3.6

4.2

7.37

7.39

0.54

(4034850) Laboratory test

2.69

1.69

14.4

17.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

3.27

1.68

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

3.27

1.68

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

140

0.40

1.66

7.2

5.1

39.67

32.23

—

(3031040) Bacteria [#/volume] in Urine by Automated count

707

1.64

5.7

4.6

—

442.00

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

114

1063

2.72

1.61

12.9

13.1

24.72

24.68

u/l

0.01

114

1031

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.16

1.61

1.2

1.6

—

(40761511) CBC panel - Blood by Automated count

112

1036

2.38

1.57

17.2

15.5

—

(3021589) Normoblasts [#/volume] in Blood

491

1.55

1.54

10.2

13.0

0.00

0.01

e9/l

0.52

397

(3019150) Specific gravity of Urine by Refractometry

234

1.63

1.53

3.9

4.2

1.02

kg/l

0.12

153

(40768797) Stomach Pathology biopsy report

151

1.74

1.49

1.4

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

2.50

1.41

1.1

1.2

—

(3047181) Lactate [Moles/volume] in Blood

2.50

1.41

3.0

5.0

1.27

1.22

mmol/l

—

(3016502) Oxygen saturation in Arterial blood

114

1.79

1.38

5.4

9.5

94.57

95.70

0.24

108

(3044941) Cell count panel - Synovial fluid

3.02

1.37

1.0

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

260

1.55

1.32

2.9

2.7

—

(3021788) Differential panel - Synovial fluid

2.85

1.30

1.0

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

150

1.66

1.26

1.7

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2.47

1.26

1.2

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

142

1.67

1.25

1.6

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

363

1.49

1.25

3.0

3.3

1522.81

1252.01

ng/l

0.19

294

(3023520) Reticulocytes [#/volume] in Blood

102

1.78

1.24

1.6

3.6

71.27

74.05

e9/l

—

(4035726) Immunohistochemistry procedure

113

0.42

1.20

1.4

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

145

1.63

1.16

1.5

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2.56

1.16

1.0

1.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2.56

1.16

1.0

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1.95

1.11

3.1

3.7

23.36

24.98

mmol/l

0.89

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

122

1.66

1.11

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.08

1.07

1.3

2.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.85

1.05

5.8

9.0

24.24

24.88

mmol/l

0.34

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.99

1.05

1.6

1.3

—

(40758558) Short blood count panel - Blood

337

1.43

1.04

6.0

7.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

158

1.56

1.04

1.7

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1.95

1.03

1.6

2.5

0.12

0.28

g/l

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.89

1.02

3.5

4.3

23.90

24.29

mmol/l

0.15

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1.82

1.01

3.9

4.6

58.31

45.31

1.41

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.82

1.01

2.7

0.73

0.63

0.74

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

107

997

1.73

0.98

20.4

17.5

76.05

77.21

ml/min/173m2

0.24

101

924

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.79

0.96

2.7

0.85

1.31

1.32

(3019309) Folate [Moles/volume] in Red Blood Cells

205

1.48

0.95

1.5

1.7

1195.27

1216.55

nmol/l

0.04

159

(3020630) Protein [Mass/volume] in Serum or Plasma

1.66

0.92

3.9

2.7

64.95

67.02

g/l

0.65

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.72

0.92

3.0

3.4

123.00

128.95

g/l

0.41

(42870588) Differential panel, method unspecified - Blood

372

1.39

0.91

5.1

5.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

442

1.36

0.86

2.2

2.1

1.34

1.36

mmol/l

0.04

352

(3005322) IgE [Units/volume] in Serum or Plasma

1.76

0.85

1.3

1.2

42.82

244.19

u/ml

0.93

(3004588) Protein electrophoresis panel - Serum or Plasma

1.66

0.82

1.3

2.6

—

(3044640) Blood type and Crossmatch panel - Blood

359

1.36

0.82

2.9

2.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1.71

0.80

1.8

2.0

1.94

6.69

ug/l

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.86

0.80

1.5

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.86

0.80

3.5

6.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

116

1.54

0.79

3.3

2.1

326.12

391.58

nmol/l

0.61

107

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.76

0.78

2.1

2.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.80

0.77

1.5

1.2

—

(3026008) Bacteria identified in Urine by Culture

334

1.35

0.76

4.4

3.2

—

(3008898) HLA-B27 [Presence]

1.89

0.75

1.0

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1.66

0.74

2.9

5.3

1.44

1.61

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.60

0.71

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1.75

0.71

1.7

4.1

44.49

45.47

mg/l

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1.75

0.71

1.7

4.1

36.60

29.68

mg/l

—

(1002224) Polysomnography panel

1.67

0.68

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.75

0.64

1.0

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1.68

0.63

3.1

5.7

1.03

0.84

—

(3032080) INR in Blood by Coagulation assay

530

1.27

0.59

13.8

14.0

1.32

1.23

inr

0.48

429

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.59

0.0

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.59

0.0

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.75

0.58

1.5

1.2

—

(3049717) Cytology report of Urine Cyto stain

1.75

0.58

1.5

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.75

0.58

1.5

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.51

0.55

1.4

1.7

—

(3000492) Spirometry study

100

1.45

0.55

1.4

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

1.53

0.52

3.5

3.8

1.95

1.53

mmol/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

102

969

1.37

0.52

4.1

4.7

1.29

1.26

mmol/l

0.20

870

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1.54

0.51

3.6

7.8

24.45

24.65

mmol/l

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

201

1.31

0.50

1.6

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1.46

0.43

2.4

3.6

10.13

701.83

u/ml

—

(3010421) pH of Blood

1.64

0.43

2.2

2.3

7.39

7.41

—

(3038515) Glucose [Moles/volume] in Venous blood

1.59

0.43

4.0

10.82

7.67

mmol/l

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

263

1.24

0.41

1.3

0.63

2.35

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.41

0.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.41

0.0

3.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

213

0.76

0.41

3.6

3.2

0.97

0.74

ug/l

—

136

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.41

0.0

1.9

—

31.76

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1.49

0.41

1.0

1.3

—

2.75

—

(1761868) Lipid panel - Serum or Plasma

401

0.82

0.40

4.0

3.6

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.39

0.0

4.5

—

95.98

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.35

0.39

1.4

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

122

0.72

0.37

4.2

8.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

453

1.18

0.34

5.2

4.0

33.87

32.82

ng/l

0.03

337

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.35

0.34

1.5

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

166

1.25

0.32

1.7

2.0

30.43

28.89

0.61

161

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.34

0.31

1.9

1.4

—

(3020891) Body temperature

1.31

0.31

4.1

4.8

36.74

36.96

°c

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

360

0.85

0.29

1.9

2.1

191.03

208.74

u/l

0.10

341

(21494755) Public health laboratory ask at order entry panel

1.25

0.26

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.69

0.25

2.8

1.4

—

(40761536) Microorganisms panel - Urine sediment

0.72

0.23

3.3

3.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1.23

0.22

4.2

1.9

1.63

1.31

mg/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

241

1.16

0.21

4.9

4.8

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.21

0.0

1.5

—

2.36

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.21

0.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

0.00

0.21

0.0

3.4

—

49.20

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

0.00

0.21

0.0

1.1

—

0.44

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

2.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.21

0.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.21

0.0

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.21

0.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.21

0.0

1.2

—

(4146454) Self-monitoring of blood glucose

0.00

0.21

0.0

3.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.20

0.0

3.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

1171.49

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.1

—

(4024509) Urine culture

1.19

0.19

1.8

1.6

—

(3025941) Bacteria identified in Stool by Culture

1.22

0.18

2.0

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

141

0.83

0.17

1.3

1.4

—

(3019060) Gas panel - Arterial blood

1.15

0.16

3.9

4.0

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

103

1.18

0.14

1.5

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.19

0.13

1.6

1.5

—

(36660697) Celiac disease serology panel - Serum

1.19

0.13

1.3

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

239

1.11

0.13

1.5

2.22

2.82

g/l

0.90

136

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

681

0.93

0.11

3.2

3.4

49.76

49.72

u/l

0.00

633

(3041096) Erythrocytes [Presence] in Urine by Automated

309

0.92

0.10

3.7

3.13

0.00

estimate

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.10

0.09

1.0

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.04

0.08

1.2

1.5

—

(3009343) pH of Capillary blood

0.81

0.08

4.7

2.9

7.41

7.43

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

122

0.89

0.07

3.3

3.5

—

(3017732) Neutrophils [#/volume] in Blood

128

1.11

0.07

1.6

3.1

4.43

4.45

e9/l

0.02

108

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

425

1.06

0.06

4.2

4.1

0.43

0.00

estimate

—

(3029937) Albumin [Presence] in Urine by Test strip

324

0.94

0.06

4.0

0.00

estimate

—

109

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

271

1.04

0.03

4.8

4.6

21.92

23.34

0.28

135

(3012095) Magnesium [Moles/volume] in Serum or Plasma

205

1.03

0.00

4.9

3.4

0.83

0.81

mmol/l

0.25

193

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.0

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.5

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.6

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.2

—

33.76

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.00

0.0

1.0

—

14.83

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.5

—

204.00

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

257.80

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.0

2.8

—

3.98

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.89

-0.00

2.5

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

11.1

—

9.19

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

6.30

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

-0.00

0.0

3.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

0.00

-0.00

0.0

1.7

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

11.0

—

16.61

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

95.63

—

(40768443) Skin Pathology biopsy report

0.94

-0.00

1.6

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

-0.00

0.0

2.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

3.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

-0.00

0.0

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

14.3

—

1115.13

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

-0.00

0.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_LIPO_INTRATHO and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_LIPO_INTRATHO	1.187 [0.88, 1.6]	0.26
Birth year	0.995 [0.99, 1.0]	0.279

During the follow-up period (1.1.1998 — 31.12.2019), 51 out of 322 females with CD2_BENIGN_LIPO_INTRATHO died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LIPO_INTRATHO.

N-year risk	Females	Males
1	0.124%	No data
5	0.725%	No data
10	1.971%	No data
15	3.655%	No data
20	6.148%	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LIPO_INTRATHO – Benign lipomatous neoplasm of of intra-abdominal organs

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign lipomatous neoplasm of of intra-abdominal organs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints